E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies. Wang W, Wang H, Liu X, Xu F, et al. BMC Cancer 2025;25:880.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang W, Wang H, Liu X, Xu F, et al. E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies. BMC Cancer 2025;25:880.
PMID: 40380087